Fractyl Health Inc. (NASDAQ: GUTS) Stock Information | RedChip

Fractyl Health Inc. (NASDAQ: GUTS) Listen to this Section


$2.39
+0.0400 ( +1.70% ) 227.6K

Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.

Market Data


Open


$2.39

Previous close


$2.35

Volume


227.6K

Market cap


$114.47M

Day range


$2.26 - $2.43

52 week range


$1.74 - $14.50

Insider Ownership Transactions

Total Amount Purchased: 5,424,171.00 | $ 12,963,768.69

Date Type Amount Purchased Purchaser
2024-04-02 Sale -250000.00 Kimber Adrian
2024-02-08 Sale -4770901.00 Bessemer Venture Partners VII L.P.
2024-02-08 Buy 1389451.00 Elia Marc
2024-02-08 Buy 5160301.00 Royan Ajay
2024-02-08 Sale -23299.00 Caplan Jay David
2024-02-08 Sale -673391.00 Corebridge DECO II, LLC
2024-02-08 Sale -283878.00 AMERICAN HOME ASSURANCE CO
2024-02-08 Sale -277890.00 MEANWELL CLIVE
2024-02-08 Sale -6523.00 Rajagopalan Harith
2024-02-08 Buy 5160301.00 Mithril LP

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 63 Aug 14, 2024
8-k 8K-related 13 Aug 14, 2024
8-k 8K-related 12 Jul 30, 2024
8-k 8K-related 12 Jun 24, 2024
3/a Insider transactions 2 May 14, 2024
8-k 8K-related 13 May 13, 2024
10-q Quarterly Reports 71 May 13, 2024
3 Insider transactions 2 Apr 02, 2024
4 Insider transactions 1 Apr 02, 2024
8-k 8K-related 13 Apr 01, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.